Aerodynamic performance measurements of a film-cooled turbine stage

"February 2001."Includes bibliographical references (p. 167-168).Thesis (Ph.D.)--Massachusetts Institute of Technology, Dept. of Aeronautics and Astronautics, 2001.The goal of this research is to measure the aerodynamic performance of a film-cooled turbine stage and to quantify the loss caused by film-cooling. A secondary goal of the research is to provide a detailed breakdown of the losses associated with film-cooling for the turbine stage being tested. The experimental work was carried out at the MIT Blowdown Turbine Facility using a highly loaded turbine stage. The Blowdown Turbine Facility is a short duration test facility capable of testing turbine stages under fully scaled conditions for a test duration of 0.5 seconds. The facility was modified to enable the measurement of the turbine mass flow and shaft torque. These newly developed measurement techniques, along with previously developed total pressure and temperature instruments, have enabled the measure- ment of the stage isentropic efficiency. A highly loaded turbine stage (without film-cooling) was designed, fabricated, and tested using the newly developed measurement techniques. The turbine stage was then modified to incorporate vane, blade and rotor casing coolant manifolds using precision electrical discharge machining. The film-cooling hole geometry was created using a laser drilling process to produce the required 43,000 cooling holes. The film-cooled stage was then tested over a range of operating conditions (pressure ratios and corrected speeds) and over a range of coolant-to-mainstream mass flow and temperature ratios.(cont.) The loss due to film-cooling is defined as the difference in performance between the film-cooled turbine and an ideal turbine with the same velocity triangles and airfoil Mach number distributions. However, there is no uncooled turbine geometry that will produce the same flow conditions as the film-cooled turbine stage, and consequently, there is no experimental baseline that can be tested to determine the loss due to film- cooling. A meanline velocity triangle model of the turbine stage was developed using published correlations and loss models to estimate the performance of this ideal stage. The model was calibrated against the baseline test results without coolant and it was then used to estimate the loss due to film-cooling. The estimated loss due to film-cooling was 3.0% at the design point, which corresponds to 0.3% per percent of coolant. The estimated repeatability (U95) for the efficiency measurement of the uncooled tur- bine geometry is ± 0.14%. Based on this measurement repeatability, the net effect of a design change can be determined with an uncertainty of just ± 0.1% if four measurements are repeated for each design configuration. The estimated measurement uncertainty for the film-cooled stage efficiency is 0.55% and for back-to-back measurements the uncertainty is 0.45%.by Rory Keogh.Ph.D

Shaft efficiency measurements of a fully scaled turbine in a short duration facility

Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Aeronautics and Astronautics, 1998.Includes bibliographical references (p. 93-94).by Rory Keogh.S.M

Second Annual Transformative Vertical Flight Concepts Workshop: Enabling New Flight Concepts Through Novel Propulsion and Energy Architectures

On August 3rd and 4th, 2015, a workshop was held at the NASA Ames Research Center, located at the Moffett Federal Airfield in California to explore the aviation communities interest in Transformative Vertical Flight (TVF) Concepts. The Workshop was sponsored by the AHS International (AHS), the American Institute of Aeronautics and Astronautics (AIAA), the National Aeronautics and Space Administration (NASA), and hosted by the NASA Aeronautics Research Institute (NARI). This second annual workshop built on the success and enthusiasm generated by the first TVF Workshop held in Washington, DC in August of 2014. The previous Workshop identified the existence of a multi-disciplinary community interested in this topic and established a consensus among the participants that opportunities to establish further collaborations in this area are warranted. The desire to conduct a series of annual workshops augmented by online virtual technical seminars to strengthen the TVF community and continue planning for advocacy and collaboration was a direct outcome of the first Workshop. The second Workshop organizers focused on four desired action-oriented outcomes. The first was to establish and document common stakeholder needs and areas of potential collaborations. This includes advocacy strategies to encourage the future success of unconventional vertiport capable flight concept solutions that are enabled by emerging technologies. The second was to assemble a community that can collaborate on new conceptual design and analysis tools to permit novel configuration paths with far greater multi-disciplinary coupling (i.e., aero-propulsive-control) to be investigated. The third was to establish a community to develop and deploy regulatory guidelines. This community would have the potential to initiate formation of an American Society for Testing and Materials (ASTM) F44 Committee Subgroup for the development of consensus-based certification standards for General Aviation scale vertiport capable flight systems. These standards need to accommodate novel fixed wing concepts that do not fit within the existing Federal Aviation Administration (FAA) rotorcraft certification framework (Code of Federal Regulations, Title 14, Chapter I, Subchapter C, Part 27). The fourth desired outcome was to launch an information campaign to ensure key U.S. Government agencies understand the potential benefits and industry interest in establishing new vertiport capable flight markets. This record of the Workshop proceedings documents Workshop activities and products including summaries of the video recorded technical presentations, overviews of three breakout sessions (Missions Operational Concepts, Prioritized Technical Challenges, Regulatory Roadmap), and a preliminary draft roadmap framework for TVF

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

An Artificial-Intelligence-Discovered Functional Ingredient, NRT_N0G5IJ, Derived from Pisum sativum, Decreases HbA1c in a Prediabetic Population

The prevalence of prediabetes is rapidly increasing, and this can lead to an increased risk for individuals to develop type 2 diabetes and associated diseases. Therefore, it is necessary to develop nutritional strategies to maintain healthy glucose levels and prevent glucose metabolism dysregulation in the general population. Functional ingredients offer great potential for the prevention of various health conditions, including blood glucose regulation, in a cost-effective manner. Using an artificial intelligence (AI) approach, a functional ingredient, NRT_N0G5IJ, was predicted and produced from Pisum sativum (pea) protein by hydrolysis and then validated. Treatment of human skeletal muscle cells with NRT_N0G5IJ significantly increased glucose uptake, indicating efficacy of this ingredient in vitro. When db/db diabetic mice were treated with NRT_N0G5IJ, we observed a significant reduction in glycated haemoglobin (HbA1c) levels and a concomitant benefit on fasting glucose. A pilot double-blinded, placebo controlled human trial in a population of healthy individuals with elevated HbA1c (5.6% to 6.4%) showed that HbA1c percentage was significantly reduced when NRT_N0G5IJ was supplemented in the diet over a 12-week period. Here, we provide evidence of an AI approach to discovery and demonstrate that a functional ingredient identified using this technology could be used as a supplement to maintain healthy glucose regulation

Irish National ICU Audit Annual Report 2021

INICUA captured activity in 22 adult public hospitals, which collectively provided 96% of Level 3 ICU care in adult HSE-funded hospitals in 2021. The ICU audit documented 12,151 admissions of 11,420 patients to 26 Units in 22 hospitals. The mean length of stay was 6.6 days. Data in this report provides detailed insights into the complexity and volume of care provided in each Unit, with implications for resource requirements when planning ICU services. A key metric in defining the complexity of care provided is the number of bed days where the Patient is undergoing invasive ventilation. The Report provides data for each Unit on (i) the total number of bed days with invasive ventilation and (ii) bed days with invasive ventilation as a percentage of total bed days.</p

Surgical site infection after gastrointestinal surgery in children : an international, multicentre, prospective cohort study

Introduction Surgical site infection (SSI) is one of the most common healthcare-associated infections (HAIs). However, there is a lack of data available about SSI in children worldwide, especially from low-income and middle-income countries. This study aimed to estimate the incidence of SSI in children and associations between SSI and morbidity across human development settings. Methods A multicentre, international, prospective, validated cohort study of children aged under 16 years undergoing clean-contaminated, contaminated or dirty gastrointestinal surgery. Any hospital in the world providing paediatric surgery was eligible to contribute data between January and July 2016. The primary outcome was the incidence of SSI by 30 days. Relationships between explanatory variables and SSI were examined using multilevel logistic regression. Countries were stratified into high development, middle development and low development groups using the United Nations Human Development Index (HDI). Results Of 1159 children across 181 hospitals in 51 countries, 523 (45 center dot 1%) children were from high HDI, 397 (34 center dot 2%) from middle HDI and 239 (20 center dot 6%) from low HDI countries. The 30-day SSI rate was 6.3% (33/523) in high HDI, 12 center dot 8% (51/397) in middle HDI and 24 center dot 7% (59/239) in low HDI countries. SSI was associated with higher incidence of 30-day mortality, intervention, organ-space infection and other HAIs, with the highest rates seen in low HDI countries. Median length of stay in patients who had an SSI was longer (7.0 days), compared with 3.0 days in patients who did not have an SSI. Use of laparoscopy was associated with significantly lower SSI rates, even after accounting for HDI. Conclusion The odds of SSI in children is nearly four times greater in low HDI compared with high HDI countries. Policies to reduce SSI should be prioritised as part of the wider global agenda.Peer reviewe

Exploring the cost-effectiveness of high versus low perioperative fraction of inspired oxygen in the prevention of surgical site infections among abdominal surgery patients in three low- and middle-income countries

Background: This study assessed the potential cost-effectiveness of high (80–100%) vs low (21–35%) fraction of inspired oxygen (FiO2) at preventing surgical site infections (SSIs) after abdominal surgery in Nigeria, India, and South Africa. Methods: Decision-analytic models were constructed using best available evidence sourced from unbundled data of an ongoing pilot trial assessing the effectiveness of high FiO2, published literature, and a cost survey in Nigeria, India, and South Africa. Effectiveness was measured as percentage of SSIs at 30 days after surgery, a healthcare perspective was adopted, and costs were reported in US dollars ($). Results: High FiO2 may be cost-effective (cheaper and effective). In Nigeria, the average cost for high FiO2 was$216 compared with $222 for low FiO2 leading to a −$6 (95% confidence interval [CI]: −$13 to −$1) difference in costs. In India, the average cost for high FiO2 was $184 compared with$195 for low FiO2 leading to a −$11 (95$15 to −$6) difference in costs. In South Africa, the average cost for high FiO2 was$1164 compared with $1257 for low FiO2 leading to a −$93 (95% CI: −$132 to −$65) difference in costs. The high FiO2 arm had few SSIs, 7.33% compared with 8.38% for low FiO2, leading to a −1.05 (95% CI: −1.14 to −0.90) percentage point reduction in SSIs. Conclusion: High FiO2 could be cost-effective at preventing SSIs in the three countries but further data from large clinical trials are required to confirm this